Clinical Outcome Assessments Toolbox for Radiopharmaceuticals

Clinical Outcome Assessments Toolbox for Radiopharmaceuticals

For nearly 40 years, the U.S. National Cancer Institute (NCI) has funded health-related quality-of-life (HRQOL) and symptom management in oncology clinical trials as a method for including a cancer patient's experience during and after treatment. The NCI's planned scope for HRQOL, symptom...

Full description

Bibliographic Details
Main Authors: Charles A. Kunos, Jacek Capala, Adam P. Dicker, Benjamin Movsas, Susan Percy Ivy, Lori M. Minasian
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
radiopharmaceutical
cancer
patient reported outcome (PRO)
digital device usage
clinical outcome assessment
radiotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01028/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01028/full

Similar Items